Implantable cardiac soft robotic sleeve: A promising technology for the millions with end‐stage heart failure in low and middle‐income countries.

The article discusses the rising prevalence of heart failure, particularly in low- and middle-income countries (LMICs), and the limitations of current treatment options such as heart transplantation and ventricular assist devices (VADs). It introduces the concept of implantable cardiac soft robotic sleeves (ICRS) as a potential solution. The ICRS utilizes soft robotics and biomimicry to replicate the natural motion of the myocardium, offering advantages such as pulsatile flow, reduced need for anticoagulation therapy, potential for miniaturization, and synchronization with the natural heart. The article highlights the implications of this technology for LMICs, including cost-effectiveness, manufacturing efficiency, increased accessibility, and long-term sustainability. However, it acknowledges the challenges that need to be addressed, such as safety and efficacy trials, cost, healthcare infrastructure, and patient selection. Despite these challenges, the ICRS represents a promising technology that could significantly benefit end-stage heart failure patients in LMICs and contribute to global health equity. The authors emphasize the importance of collaboration among stakeholders to accelerate the development and deployment of this technology. Overall, the article presents the ICRS as an innovative solution to address the pressing health challenges of heart failure and bridge healthcare disparities. [Extracted from the article]